UBS cuts DraftKings stock price target on revenue normalization
UBS reduced its price target on DraftKings (DKNG) to $48 from $49, maintaining a Buy rating. The company reported a 4.6% revenue decline but expects fiscal 2026 revenue of $6.5B-$6.9B. UBS cited sports outcomes and customer acquisition costs as key factors. DKNG shares are down 9% over the past week and 35% year-to-date, though some analysts consider it undervalued.
How this was made
The 30-second read
Why it matters
Analyst target adjustment reflects concerns over promotional spend and hold rates, but the buy rating indicates belief in longer‑term upside.
Market read
First report of UBS price‑target change following DraftKings Q2 earnings, providing fresh guidance for traders.
What to watch
Potential upside from upcoming major sports events and parlay volume growth.
Background
DraftKings reported a 4.6% revenue decline but highlighted a 10% YoY increase when normalized for outcomes and acquisition costs.
Ticker impact
UBS lowered its price target on DraftKings to $48 after the company's Q2 earnings and revenue guidance update.
Potential short-term pullback toward $48 target.
Analyst downgrade based on revenue normalization and higher acquisition costs.
Market effects
May pressure other sports‑betting stocks as analysts scrutinize hold rates and promo spend.
U.S. sports‑betting sector sees modest downside pressure.
Limited to U.S. listed betting operators.
Counterpoint
Despite the target cut, the stock remains undervalued at current levels and could rebound on improved hold rates.
Key entities
- AnalystUBS
Equity research firm that revised DraftKings price target.
- AnalystNeedham
Maintained a $35 price target and Buy rating.
